Visit COVID-19 resources

[Skip to Content]

Eye Journal

Comment on: ‘Central retinal vein occlusion: modifying current treatment protocols’ – (Eye 30, 1395 (October 2016))

Oct 06
2016

Comment on: ‘Central retinal vein occlusion: modifying current treatment protocols’ Eye 30, 1395 (October 2016). doi:10.1038/eye.2016.83 Authors: D Călugăru & M Călugăru

  • 6 October 2016

Response to: ‘Comment on Central retinal vein occlusion: modifying current treatment protocols’ – (Eye 30, 1396 (October 2016))

Oct 06
2016

Response to: ‘Comment on Central retinal vein occlusion: modifying current treatment protocols’ Eye 30, 1396 (October 2016). doi:10.1038/eye.2016.84 Authors: M Ashraf, A A R Souka & R P Singh

  • 6 October 2016

Stability and safety of MA50 intraocular lens placed in the sulcus – (Eye 30, 1397 (October 2016))

Oct 06
2016

Stability and safety of MA50 intraocular lens placed in the sulcus Eye 30, 1397 (October 2016). doi:10.1038/eye.2016.91 Authors: A Sandhu & J Clarke

  • 6 October 2016

Response to Dr Sandhu and Dr Clarke – (Eye 30, 1397 (October 2016))

Oct 06
2016

Response to Dr Sandhu and Dr Clarke Eye 30, 1397 (October 2016). doi:10.1038/eye.2016.92 Authors: P S Kemp & T A Oetting

  • 6 October 2016

Comment on ‘Evaluation of choroidal thickness in patients with scleroderma’ – (Eye 30, 1398 (October 2016))

Oct 06
2016

Comment on ‘Evaluation of choroidal thickness in patients with scleroderma’ Eye 30, 1398 (October 2016). doi:10.1038/eye.2016.101 Author: S Uzun

  • 6 October 2016